UMIN-CTR Clinical Trial

Recruitment status Completed
Unique ID issued by UMIN UMIN000025016
Receipt No. R000028763
Official scientific title of the study The effect of coffee-derived mannooligosaccharides on the intestinal condition - A systematic review with meta-analysis
Date of disclosure of the study information 2017/06/30
Last modified on 2017/08/03 (Ver. 4)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Official scientific title of the study The effect of coffee-derived mannooligosaccharides on the intestinal condition - A systematic review with meta-analysis
Title of the study (Brief title) A systematic review of coffee-derived mannooligosaccharides
Region
Japan

Condition
Condition Healthy adult volunteers or ones with a tendency for constipation
Classification by specialty
Adult
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 The objective of this review is to evaluate the effect of coffee derived-mannooligosaccharides on the intestinal condition by performing a systematic review with meta-analysis of randomized controlled trials.
Basic objectives2 Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes The primary outcome measures are defecation days/week, defecation frequency/week, fecal Bifidobacterium count and the occupancy rate of Bifidobacterium in the total fecal microbiota.
Key secondary outcomes Defecation amount per week is a secondary outcome.

Base
Study type Others,meta-analysis etc

Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
20 years-old <=
Age-upper limit

Not applicable
Gender Male and Female
Key inclusion criteria Systematic literature search using scientific databases and registered databases for clinical trials and systematic review will be performed. Key inclusion criteria are as follows:
Participants: Healthy adults or adults with a tendency for constipation
Intervention: Intake for more than 2 weeks
Comparison: Placebo controll, in principle
Outcome: Regulation of intestinal condition(see above outcome column)
Study design: Adopt intervention study (Randomized parallel group comparison test, randomized cross over test, quasi-randomized parallel group comparison test, quasi-randomized cross over test, non-randomized parallel group comparison test)
Key exclusion criteria We will exclude the literature which does not meet the key inclusion criteria.
Target sample size 0

Research contact person
Name of lead principal investigator Shigeyoshi Fujii
Organization Ajinomoto General Foods, Inc.
Division name Technical Research and Development
Address Sanken Building, 3-25-1, Hyakunin-cho Shinjuku-ku, Tokyo 169-0073 Japan
TEL 03-5338-6713
Email Shigeyoshi_Fujii@agf.co.jp

Public contact
Name of contact person Shigeyoshi Fujii
Organization Ajinomoto General Foods, Inc.
Division name Technical Research and Development
Address Sanken Building, 3-25-1, Hyakunin-cho Shinjuku-ku, Tokyo 169-0073 Japan
TEL 03-5338-6713
Homepage URL
Email Shigeyoshi_Fujii@agf.co.jp

Sponsor
Institute Ajinomoto General Foods, Inc.
Institute
Department

Funding Source
Organization Ajinomoto General Foods, Inc.
Organization
Division
Category of Funding Organization Self funding
Nationality of Funding Organization

Other related organizations
Co-sponsor Review team
Mr. Kenji Yamamura, Technical Research & Development. Ajinomoto General Foods, Inc.
Ms. Kaho Kanatani, Technical Research & Development, Ajinomoto General Foods, Inc.
Research Collaborator
Professor Hiroharu Kamioka, Faculty of Regional Environment Science, Tokyo University of Agriculture
Dr. Takahiro Yoshizaki, Department of Nutritional Science, Department of Toyo University
Ms. Mari Makishi, Toho University Narashino Media Center
Name of secondary funder(s)

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2017 Year 06 Month 30 Day

Progress
Recruitment status Completed
Date of protocol fixation
2016 Year 11 Month 17 Day
Anticipated trial start date
2016 Year 11 Month 28 Day
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Related information
URL releasing protocol
Publication of results Published
URL releasing results http://www.lifescience.co.jp/yk/yk17/july/ab1.html
Results
Other related information Search: We will systematically search scientific databases and registered databases for clinical trials and systematic review.
The search is performed by a specific searcher (hospital librarians, MM) who is qualified in medical information handling, and who is sophisticated in searches of clinical trials. Two authors will independently screen the literature based on key inclusion criteria.
Risk of bias (quality) assessment
Two authors will independently assess risk of bias based on GRADE. Agreement between the two review authors with regard to the primary outcomes and the risk of bias items will be reported as concordance rate and kappa coefficient. Indirectness, inconsistency and imprecision will be also assessed.
Meta-analysis: Meta-analysis for synthetic data using Review Manager(RevMan 5.2) will be performed by TY who is highly experienced in handling meta-analysis. Estimated effect size will be expressed as standardized mean difference and 95% CI will be also calculated using randomized effect model. Forest plot will be conducted and heterogeneity will be also assessed. Publication bias will be assessed by funnel plot.
Subgroup analysis: We will perform subgroup analysis for the intake amount of coffee-derived mannooligosaccharides and participants restricted to ones with a tendency for constipation. We will also conduct sub-group analysis using only randomized parallel-group trial. If the RCT includes extremely large sample size, this RCT will be excluded for the analysis.

Management information
Registered date
2016 Year 11 Month 28 Day
Last modified on
2017 Year 08 Month 03 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000028763